Synopsis of recent research by authors named "Wenjia Ai"
- Wenjia Ai's recent research focuses on vascular health, investigating treatments for conditions such as abdominal aortic aneurysms (AAA) and rheumatoid arthritis (RA), and evaluating the clinical management of these diseases during acute situations like the COVID-19 pandemic
- Significant findings include the effectiveness of the gasdermin D inhibitor necrosulfonamide in alleviating AAA symptoms in mice and the association of inflammatory markers with depression in RA patients, offering insights into potential therapeutic strategies for these conditions
- Additionally, Ai has contributed to the body of knowledge through systematic reviews and meta-analyses on endovascular treatment modalities, highlighting their comparative effectiveness for various vascular lesions and their implications for improving patient care outcomes